Ozempic (active substance semaglutide) belongs to the class of GLP-1 receptor agonists. Below we explain what this drug is officially prescribed for and how it works at the mechanism level. This is educational material, not a guide to self-administration.

Important. Ozempic is a prescription medicine and a registered trademark of Novo Nordisk. The treatment regimen, dose and duration are set by a physician only, based on the manufacturer's official label and the state of the individual patient. This article contains no dosing schedules for self-use. Longeva research semaglutide is intended for laboratory research only (research use only).

What Ozempic is used for

According to its approved indications, Ozempic is used in adults with type 2 diabetes to improve glycemic control, as an addition to diet and physical activity. In a number of jurisdictions the indications also include reducing the risk of major cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.

An important nuance that is often confused: "Ozempic" itself is officially not a weight-loss drug. For weight management the same semaglutide is registered under a separate brand, Wegovy, with different indications and a different regimen. So queries like "ozempic for weight loss" refer to use outside the approved indications, a decision only a physician can make.

How semaglutide works (mechanism)

Semaglutide mimics the action of the natural hormone GLP-1 (glucagon-like peptide-1), which is released in the gut in response to food intake. By activating GLP-1 receptors, it affects several processes at once:

  • stimulates insulin release in a glucose-dependent way (that is, mainly when glucose levels are high);
  • suppresses glucagon release, which raises blood sugar;
  • slows gastric emptying, so the feeling of fullness lasts longer;
  • acts on appetite centers in the brain, reducing hunger.

That is why drugs of this class produce a glycemic and also a weight effect, and that is why they have become the subject of wide interest.

Form and route of use (general)

Ozempic comes as a prefilled pen for subcutaneous injection once a week. Rybelsus is the oral (tablet) form of semaglutide. The specific dose, titration and duration are a matter for a physician's prescription, not self-selection. We deliberately give no step-by-step injection schedules: improper use of prescription drugs carries real risks.

Side effects and precautions

The most common documented side effects of GLP-1 agonists are gastrointestinal: nausea, vomiting, diarrhea, constipation, abdominal pain. They are usually more pronounced at the start and when the dose is increased. There are also more serious precautions (for example, regarding pancreatitis and contraindications) that are set out in detail in the official label and that a physician must assess. Self-administration without medical supervision is dangerous.

Semaglutide as a molecule and as a research reagent

If you are interested in semaglutide from the scientific side, as a molecule, its pharmacology and study data, start with our semaglutide monograph and the comparison of semaglutide / tirzepatide / retatrutide. Longeva supplies semaglutide for laboratory research only; it is not Ozempic and not a treatment.

Summary. Ozempic is a prescription diabetes drug that works as a GLP-1 agonist. Any use of it (and especially off-label, for weight) is possible only when prescribed and supervised by a physician.